Table 1 Demographic and clinical features of COVID-19 positive cases from HRSM and HB Brazilian hospitals (n = 236)
Values | |
|---|---|
Woman, n (%) | 144 (61.0%) |
Age, mean (SD), range, y | 41.2 (12.8) 19.0–81.0 |
Age distribution, n (%) | |
18–29 y | 46 (19.5%) |
30–49 y | 129 (54.7%) |
50–64 y | 48 (20.3%) |
> 64 y | 13 (5.5%) |
Body mass index (BMI), mean (SD), range, kg/m2 | 27.8 (5.7) 17.1–51.3 |
WHO BMI classification, n (%)* | |
Underweight | 4 (1.8%) |
Normal | 63 (28.8%) |
Overweight | 86 (39.3%) |
Obese | 61 (27.9%) |
Number of reported symptoms during acute infection phase, mean (SD), range | 4.1 (3.0) 0–12 |
Number of reported symptoms during LC (5–8 months), mean (SD), range | 1.3 (1.8) 0–10 |
Distribution of symptoms count during acute phase, n (%) | |
None | 30 (12.7%) |
1–2 | 43 (18.2%) |
3–5 | 93 (39.4%) |
6–8 | 43 (18.2%) |
9–12 | 27 (11.4%) |
Distribution of symptoms count during LC (5–8 months), n (%) | |
None | 102 (43.2%) |
1–2 | 106 (44.9%) |
3–5 | 19 (8.1%) |
6–8 | 5 (2.1%) |
9–10 | 4 (1.7) |
Persistent symptoms | |
General distribution, n (%) | |
None | 138 (58.5%) |
1 or more persistent symptom | 98 (41.5%) |
Range, n (%) | |
1–2 | 86 (36.4%) |
≧ 3 | 12 (5.1%) |
New-onset symptoms, n (%) | |
General distribution, n (%) | |
None | 167 (70.8%) |
1 or more new-onset symptom | 69 (29.2%) |
Range of new-onset symptoms, n (%) | |
1–2 | 55 (23.3%) |
≧ 3 | 14 (5.9%) |
Comorbidities, n (%) | |
Essential hypertension | 44 (18.6%) |
Diabetes | 21 (8.9%) |
Chronic lung disorder (asthma, COPD) | 17 (7.2%) |
Chronic kidney disease | 8 (3.4%) |
Immunosuppression | 7 (3%) |
Heart disorder (coronary artery disease or valve disorder or heart failure) | 6 (2.5%) |
Neoplasia | 3 (1.3%) |
Solid-organ or bone marrow transplant | 2 (0.8%) |
No known diagnosis of chronic disorder | 117 (49.6%) |
COVID-19 treatment scenario (n, %) | |
Non-hospitalized patients | 201 (86.3%) |
Hospitalized patients (COVID-19 hospital ward) | 32 (13.7%) |
Critical care–intensive care unit (ICU) | 8 (3.4%) |
Need for support therapy (n, %) | |
Oxygen supplementation | 24 (10.4%) |
Mechanical ventilation | 3 (1.3%) |
Smoker, n (%) | 8 (3.4%) |